Alzheimer; News from the web:
Researchers from Cleveland Clinic’s Lerner Research Institute and Anesthesiology Institute found that the compound MDA7 induced beneficial immune responses that limited the development of Alzheimer’s disease.
Treatment with the compound restored cognition, memory and synaptic plasticity – a key neurological foundation of learning and memory – in an animal model.
“Cleveland Clinic dedicated two years of research into the examination of this compound and our findings show it could represent a novel therapeutic target in the treatment of Alzheimer’s disease,” Mohamed Naguib, lead researcher said in a statement.
Read all about it HERE
visit us at AlzheimerHeadlines.com